Dietary intervention prevents dyslipidemia associated with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected individuals: A randomized trial

Journal of the American College of Cardiology

Volumn 59, Issue 11, 2012, Pages 979-988

  Lazzaretti, Rosmeri K ^a   Kuhmmer, Regina ^a   Sprinz, Eduardo ^a,b   Polanczyk, Carsi A ^a,b   Ribeiro, Jorge P ^a,b  

^a Hospital de Clnicas de Porto Alegre   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

AIDS; cholesterol; nutrition

Indexed keywords

ATAZANAVIR; ATAZANAVIR PLUS RITONAVIR; EFAVIRENZ; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INDINAVIR PLUS RITONAVIR; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RITONAVIR; STAVUDINE; TRIACYLGLYCEROL; ZIDOVUDINE;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET THERAPY; DRUG EFFICACY; DRUG SAFETY; DYSLIPIDEMIA; ENVIRONMENTAL FACTOR; FEEDING BEHAVIOR; FEMALE; FOOD INTAKE; HEREDITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VIRUS LOAD; WAIST HIP RATIO;

ADULT; ANTHROPOMETRY; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHOLESTEROL; DYSLIPIDEMIAS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 84857829318     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.11.038     Document Type: Article

References (37)

1. J.R. Marins, L.F. Jamal, S.Y. Chen Dramatic improvement in survival among adult Brazilian AIDS patients AIDS 17 2003 1675 1682 (Pubitemid 36951688)
2. S. Grinspoon, A. Carr Cardiovascular risk and body-fat abnormalities in HIV-infected adults N Engl J Med 352 2005 48 62 (Pubitemid 40075680)
3. M.P. Dub, J.H. Stein, J.A. Aberg Adult AIDS Clinical Trials Group Cardiovascular Subcommittee; HIV Medical Association of the Infectious Disease Society of America Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group Clin Infect Dis 37 2003 613 627 (Pubitemid 37100800)
4. A.H. Shevitz, T.A. Knox Nutrition in the era of highly active antiretroviral therapy Clin Infect Dis 32 2001 1769 1775 (Pubitemid 32532007)
5. M. Schambelan, C.A. Benson, A. Carr International AIDS SocietyUSA Management of metabolic complications associated with antiretroviral therapy for HIV-1 Infection: recommendations of an International AIDS SocietyUSA Panel J Acquir Immune Defic Syndr 31 2002 257 275 (Pubitemid 35278626)
6. D. Turcinov, C. Stanley, J.A. Canchola, G.W. Rutherford, T.E. Novotny, J. Begovac Dyslipidemia and adherence to the Mediterranean diet in Croatian HIV-infected patients during the first year of highly active antiretroviral therapy Coll Antropol 33 2009 423 430
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
8. S. Yu-Poth, G. Zhao, T. Etherton, M. Naglak, S. Jonnalagadda, P.M. Kris-Etherton Effects of the National Cholesterol Education Program's Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis Am J Clin Nutr 69 1999 632 646 (Pubitemid 29193386)
9. J.A. Halbert, C.A. Silagy, P. Finucane, R.T. Withers, P.A. Hamdorf Exercise training and blood lipids in hyper-lipemic and normolipemic adults: a meta-analysis of randomized-controlled trials Eur J Clin Nutr 53 1999 514 522 (Pubitemid 29352182)
10. M.J. Batterham, D. Brown, C. Workman Modifying dietary fat intake can reduce serum cholesterol in HIV-associated hypercholesterolemia AIDS 17 2003 1414 1416 (Pubitemid 36819867)
11. G.J. Thni, C. Fedou, J.F. Brun Reduction of fat accumulation and lipid disorders by individualized light aerobic training in human immunodeficiency virus infected patients with lipodystrophy and/or dyslipidemia Diabetes Metab 28 2002 397 404 (Pubitemid 35434314)
12. L. Terry, E. Sprinz, R. Stein, N.B. Medeiros, J. Oliveira, J.P. Ribeiro Exercise training in HIV-1-infected individuals with dyslipidemia and lipodystrophy Med Sci Sports Exer 38 2006 411 417 (Pubitemid 43364114)
13. K.V. Fitch, E.J. Anderson, J.L. Hubbard Effects of a lifestyle modification program in HIV-infected patients with the metabolic syndrome AIDS 20 2006 1843 1850 (Pubitemid 44358902)
14. E. Schneider, S. Whitmore, K.M. Glynn, K. Dominguez, A. Mitsch, M.T. McKenna Centers for Disease Control and Prevention (CDC) Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 yearsUnited States, 2008 MMWR Recomm Rep 57 RR-10 2008 1 12
15. C.B. Zabotto, R.P.T. Viana, M.F. Gil Photographic references for dietary recall: portions and utensils 1996 Unicamp Campinas, Brazil
16. E.A. Soares, E.S. Portella, M. Ishii List of 320 household measures of foods and their weight 1991 Ceane So Paulo, Brazil
17. A.B.V. Pinheiro, E.M.A. Lacerda, E.H. Benzecry, M.C.S. Gomes, V.M. Costa Table for the evaluation of food intake in household measures 4th edition 1998 Atheneu Rio de Janeiro, Brazil
18. W.T. Friedwald, R.I. Levy, D.S. Fredrickson Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
19. S. Tsiodras, C. Mantzoros, S. Hammer, M. Samore Effects of protease inhibitors on hyperglycemia, hyperlipidemia and lipodystrophy: a 5-year cohort study Arch Intern Med 160 2000 2050 2056 (Pubitemid 30437589)
20. G. Molenberghs, G. Verbeke A review on linear mixed models for longitudinal data, possibly subject to dropout Stat Model 1 2001 235 269
21. Ministrio da Sade, Secretaria de Vigilncia em Sade, Programa Nacional de DST e AIDS Recommendations of anti-retroviral therapy for adults and adolescents infected by HIV 2008 2008 Braslia, Brazil http://www.ensp.fiocruz.br/portal- ensp/judicializacao/pdfs/491.pdf Accessed October 31, 2011
22. A. Barrios, F. Blanco, T. Garca-Benayas Effect of dietary intervention on highly active antiretroviral therapy-related dyslipidaemia AIDS 16 2002 2079 2081 (Pubitemid 35205273)
23. E.J. Schaefer Lipoproteins, nutrition, and heart disease Am J Clin Nutr 75 2002 191 212 (Pubitemid 34101203)
24. G. Moyle, M. Lloyd, B. Reynolds, C. Baldwin, S. Mandalia, B. Gazzard Dietary advice with or without pravastatin for the management of hypercholesterolemia associated with protease inhibitor therapy AIDS 15 2001 1503 1508 (Pubitemid 32744597)
25. J. Miller, D. Brown, J. Amin A randomized, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridemia AIDS 16 2002 2195 2200 (Pubitemid 35387274)
26. M.N. Woods, C.A. Wanke, P.R. Ling Effect of a dietary intervention and n-3 fatty acid supplementation on measures of serum lipid and insulin sensitivity in persons with HIV Am J Clin Nutr 90 2009 1566 1578
27. C. Grunfeld, M. Pang, W. Doerrler, J.K. Shigenaga, P. Jensen, K.R. Feingold Lipids, lipoproteins, triglyceride clearance and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome J Clin Endocrinol Metab 74 1992 1045 1052
28. G. Shor-Posner, A. Basit, Y. Lu Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection Am J Med 94 1993 515 519 (Pubitemid 23142967)
29. S.A. Riddler, E. Smit, S.R. Cole Impact of HIV infection and HAART on serum lipids in men JAMA 289 2003 2978 2982 (Pubitemid 37430100)
30. E. Negredo, J. Ribalta, R. Ferr Efavirenz induces a striking and generalized increase of HDL-cholesterol in HIV-infected patients AIDS 18 2004 819 821 (Pubitemid 38535014)
31. C. Fisac, E. Fumero, M. Crespo Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine AIDS 19 2005 917 925 (Pubitemid 40834934)
32. E. Sprinz, R.K. Lazzaretti, R. Kuhmmer, J.P. Ribeiro Dyslipidemia in HIV-infected individuals Braz J Infec Dis 14 2010 575 588
33. N. Crum-Cianflone, M.P. Roediger, L. Eberly Increasing rates of obesity among HIV-infected persons during the HIV epidemic PLoS ONE 5 2010 e10106
34. G. Block A review of validations of dietary assessment methods Am J Epidemiol 115 1982 492 505 (Pubitemid 12147721)
35. C.M. Shikuma, Y. Yang, M.J. Glesby Metabolic effects of protease inhibitor-sparing antiretroviral regimens given as initial treatment of HIV-1 infection (AIDS Clinical Trials Group Study A5095) J Acquir Immune Defic Syndr 44 2007 540 550 (Pubitemid 46594897)
36. U. Mbius, M. Lubach-Ruitman, B. Castro-Frenzel Switching to atazanavir improves metabolic disorders in antiretroviral-experienced patients with severe hyperlipidemia J Acquir Immune Defic Syndr 39 2005 174 180 (Pubitemid 40741115)
37. C. Baigent, A. Keech, P.M. Kearney Cholesterol Treatment Trialists' (CTT) Collaborators Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278